FDA Approves Camizestrant for ESR-1 Mutated Breast Cancer
FDA Approves Camizestrant for ESR-1 Mutated Breast Cancer Breast Cancer Research Foundation | BCRF
677 материалов по теме, собраны автоматически из проверенных источников
FDA Approves Camizestrant for ESR-1 Mutated Breast Cancer Breast Cancer Research Foundation | BCRF
CDMRP Breast Cancer Clinical Research Extension Award 2026 oncodaily.com
A breast cancer survivor will discuss Anixa's vaccine on TV Stock Titan
Маргарита Симоньян: «Читаю, что я победила рак груди, хотя это не правда» StarHit
«Я не победила рак груди»: Маргарита Симоньян откровенно рассказала о своей борьбе с тяжелой болезнью The Voice Mag
«Я не победила рак груди»: Маргарита Симоньян откровенно рассказала о своей борьбе с тяжелой болезнью The Voice Mag
Breast cancer often grows in tissue that is unusually dense. That's why clinicians flag women with this kind of breast tissue for follow-up after a mammogram.
Beyond A Single Disease: Traversing Complexity In Breast Cancer Clinical Development Clinical Leader
The U.S. Food and Drug Administration (FDA) has approved a new daily pill for adults with advanced breast cancer whose tumors have found a way around their current treatment.
Astrazeneca Secures FDA Approval for New Breast Cancer Treatment Benzinga
FDA Approves Camizestrant Combination for Advanced Breast Cancer Oncology News Central
FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer Fierce Pharma
BriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center Investing News Network
84-летний мужчина неожиданно обнаружил у себя рак груди. Vietnam.vn
BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center Yahoo! Finance Canada